Jeffrey Chodakewitz

2015

In 2015, Jeffrey Chodakewitz earned a total compensation of $7.8M as EVP & Chief Medical Officer at Vertex Pharmaceuticals, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$617,382
Option Awards$4,700,056
Salary$615,231
Stock Awards$1,882,493
Other$15,254
Total$7,830,416

Chodakewitz received $4.7M in option awards, accounting for 60% of the total pay in 2015.

Chodakewitz also received $617.4K in non-equity incentive plan, $615.2K in salary, $1.9M in stock awards and $15.3K in other compensation.

Rankings

In 2015, Jeffrey Chodakewitz's compensation ranked 816th out of 13,638 executives tracked by ExecPay. In other words, Chodakewitz earned more than 94.0% of executives.

ClassificationRankingPercentile
All
816
out of 13,638
94th
Division
Manufacturing
289
out of 5,190
94th
Major group
Chemicals And Allied Products
103
out of 1,854
94th
Industry group
Drugs
81
out of 1,528
95th
Industry
Pharmaceutical Preparations
66
out of 1,182
94th
Source: SEC filing on April 29, 2016.

Chodakewitz's colleagues

We found four more compensation records of executives who worked with Jeffrey Chodakewitz at Vertex Pharmaceuticals in 2015.

2015

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2015

David Altshuler

Vertex Pharmaceuticals

Chief Scientific Officer

2015

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2015

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

News

In-depth

You may also like